Sort
326,823 grants matching “clinical trial”
T-Cell Receptor Gene Therapy for Human Cancers-Cures
$2,287,338Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,287,306Michael S Rafii · University Of Southern California · R33 · FY2023 · AG
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,287,227Kathleen Theresa Brady · Medical University Of South Carolina · UL1 · FY2010 · RR
Genetics and Epigenetics of Cardiovascular Disease
$2,287,092Gary Gibbons · National Human Genome Research Institute · ZIA · FY2021 · HG
Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)
$2,287,091Wesley H Self · Vanderbilt University Medical Center · U01 · FY2023 · HL
PREcision MEDicine In Achalasia--PREMEDIA
$2,287,046John E Pandolfino · Northwestern University At Chicago · U01 · FY2025 · DK
A Massive Library of AAVs to Target Transcriptionally-Defined Primate Cell Types
$2,287,014William Richard Stauffer · University Of Pittsburgh At Pittsburgh · UG3 · FY2019 · MH
ARMADA: Advancing Reliable Measurement in Alzheimer's Disease and cognitive Aging
$2,286,972Richard Gershon · Northwestern University At Chicago · U2C · FY2019 · AG
VCID Biomarkers Coordinating Center
$2,286,910Steven M Greenberg · Massachusetts General Hospital · U24 · FY2025 · NS
Dental PBRN Network Chair
$2,286,769Gregg H Gilbert · University Of Alabama At Birmingham · U01 · FY2011 · DE
Mayo Clinic Hepatobiliary SPORE
$2,286,710Mark A. Mc Niven · Mayo Clinic Rochester · P50 · FY2025 · CA
S.P.O.R.E. in Prostate Cancer
$2,286,693University Of Michigan At Ann Arbor · P50 · FY2004 · CA
SPORE in Soft Tissue Sarcoma
$2,286,505Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
Pharmacokinetics and Drug Metabolism
$2,286,500Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Identification of Mild Cognitive Impairment using Machine Learning from Language and Behavior Markers
$2,286,356Jiayu Zhou · Michigan State University · RF1 · FY2021 · AG
Cancer and Leukemia Group B CCOP Research Base
$2,286,202Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2012 · CA
Radiation and checkpoint blockade for cancer immune therapy
$2,286,184Robert H Vonderheide · University Of Pennsylvania · P01 · FY2019 · CA
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
$2,286,172Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mayo Clinic Breast Cancer SPORE
$2,285,993Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2023 · CA
A defend and destroy approach to curing HIV
$2,285,732David T Scadden · Harvard University · U19 · FY2016 · HL
A defend and destroy approach to curing HIV
$2,285,732David T Scadden · Harvard University · U19 · FY2017 · HL
Genomic and Metabolomic Data Integration in a Longitudinal Cohort at Risk for Alzheimer's Disease
$2,285,690Corinne D. Engelman · University Of Wisconsin-Madison · RF1 · FY2022 · AG
Development of New Antitumor Agents
$2,285,466Southern Research Institute · P01 · FY2005 · CA
Clinical and Translational Science Collaborative of Cleveland
$2,285,193Pamela B Davis · Case Western Reserve University · KL2 · FY2012 · TR
ECOG-ACRIN Biorepositories to Support NCTN
$2,285,075Ignacio I. Wistuba · Ecog-Acrin Medical Research Foundation · U24 · FY2015 · CA